Novan Inc (NOVN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0941 -0.0311 (-24.84%) 07/25/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.0941 unch (unch) -
for Tue, Jul 25th, 2023
Results
download Want to compare other data? Select Fields| Symbol | NOVN | RDHL | QLGN | ||
| Company | Novan Inc | Redhill Biophrma ADR | Qualigen Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.1368 | 2.70 | 3.05 | ||
| High | 0.1396 | 2.70 | 3.30 | ||
| Low | 0.0820 | 2.29 | 2.85 | ||
| Last | 0.0941 | 2.41 | 3.00 | ||
| Change | -0.0311 | -0.37 | -0.05 | ||
| % Change | -24.84% | -13.31% | -1.64% | ||
| Volume | 7,190,000 | 34,300 | 24,900 | ||
| 20-Day Average Volume | 2,815,160 | 100,035 | 124,790 | ||
| Previous Close | 0.1252 | 2.78 | 3.05 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.3778 | 2.63 | 3.28 | ||
| 20-Day Raw Stochastic | 2.23% | 40.67% | 12.82% | ||
| 20-Day Relative Strength | 26.82% | 37.06% | 41.98% | ||
| Weighted Alpha | -79.79 | -77.94 | -84.38 | ||
| Today's Opinion | 100% Sell | 100% Sell | 96% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 96% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -44.12% since 07/18/23 | +23.59% since 04/04/25 | -4.15% since 04/04/25 | ||
| Low | 0.0820 on 07/25/23 | 1.80 on 04/07/25 | 2.85 on 04/11/25 | ||
| High | 0.1939 on 07/19/23 | 3.30 on 04/10/25 | 3.43 on 04/10/25 | ||
| 1-Month | |||||
| %Chg | -77.60% since 06/23/23 | -13.62% since 03/11/25 | -1.32% since 03/11/25 | ||
| Low | 0.0820 on 07/25/23 | 1.80 on 04/07/25 | 2.85 on 04/11/25 | ||
| High | 0.6252 on 07/12/23 | 3.30 on 04/10/25 | 4.02 on 03/28/25 | ||
| 3-Month | |||||
| %Chg | -92.65% since 04/25/23 | -58.88% since 01/10/25 | -29.91% since 01/10/25 | ||
| Low | 0.0820 on 07/25/23 | 1.80 on 04/07/25 | 2.85 on 04/11/25 | ||
| High | 1.3786 on 05/31/23 | 6.80 on 01/24/25 | 4.58 on 01/24/25 | ||
| 6-Month | |||||
| %Chg | -93.37% since 01/25/23 | -69.92% since 10/11/24 | -64.26% since 10/11/24 | ||
| Low | 0.0820 on 07/25/23 | 1.80 on 04/07/25 | 2.85 on 04/11/25 | ||
| High | 1.8200 on 01/31/23 | 9.00 on 10/21/24 | 10.45 on 10/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,636 | 3,086 | 2,209 | ||
| Shares Outstanding, K | 28,015 | 1,281 | 736 | ||
| Annual Sales | 23,680,000 | 6,530,000 | 0 | ||
| Annual Net Income | -31,310,000 | 23,920,000 | -13,420,000 | ||
| Last Quarter Sales | 3,170,000 | 1,800,000 | 0 | ||
| Last Quarter Net Income | -14,120,000 | 101,240,000 | -1,790,000 | ||
| 60-Month Beta | -0.06 | 4.44 | 0.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 05/15/23 | N/A on 08/17/23 | -4.70 on 11/14/24 | ||
| Latest Earnings Date | 08/10/23 | 04/14/25 | 04/04/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||